Medicorp

Medicorp, Inc. was a Canadian biotechnology company based in Montreal that specialized in the development and manufacturing of monoclonal antibodies, recombinant proteins, and diagnostic reagents. The company established a strong reputation for providing high-quality biological tools for research and clinical diagnostics, particularly in the fields of oncology and infectious diseases. Medicorp's product portfolio included a wide range of antibodies targeting tumor markers such as CEA and PSA, as well as specialized reagents for immunohistochemistry and flow cytometry. In 2004, the company was acquired by Bio-Rad Laboratories, which integrated Medicorp's technologies and product lines into its Life Science and Clinical Diagnostics divisions. This acquisition allowed Bio-Rad to significantly expand its presence in the antibody and diagnostic reagent markets.